Pelthos Therapeutics Inc.

NYSE:PTHS

Biological Products, (No Diagnostic Substances)·DURHAM, NC

CEO

Plesha Scott M.

Financials

8 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

3 shown

Filed	Period
11/13/25	Q4 FY2025	→
9/16/25	Q3 FY2025	→
8/18/25	Q3 FY2025	→

News (8-K)

22 shown

Filed	Type	Description
1/13/26	Agreement	Entry into a Material Definitive Agreement	→
1/12/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/2/26	Agreement	Entry into a Material Definitive Agreement	→
12/23/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/17/25	Vote	Submission of Matters to a Vote of Security Holders	→
11/7/25	Agreement	FORM 8K	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/13/26	424B3	424B3	→
2/2/26	S-3	S-3	→
12/1/25	ARS	ARS	→
9/29/25	424B3	424B3	→
9/19/25	S-3/A	S-3/A	→
8/28/25	S-3	S-3	→
↓

Filing History(203 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-055097

—

12.0 KB

424B3

Feb 13, 2026

0001753926-26-000321424B3

—

568.2 KB

EFFECT

Feb 9, 2026

9999999995-26-000493

—

1.9 KB

SCHEDULE 13G/A

Feb 5, 2026

0001753926-26-000273

—

15.3 KB

S-3

Feb 2, 2026

0001753926-26-000231S-3

—

2.2 MB

8-K

Jan 13, 2026

0001753926-26-0000978-K

Jan 12, 2026

904.8 KB

8-K

Jan 12, 2026

0001753926-26-0000948-K

Jan 6, 2026

6.5 MB

8-K

Jan 2, 2026

0001753926-26-0000108-K

Dec 23, 2025

427.3 KB

Dec 29, 2025

0001753926-25-001991

Dec 23, 2025

5.3 KB

Dec 29, 2025

0001753926-25-001990

Dec 23, 2025

3.2 KB

8-K

Dec 23, 2025

0001753926-25-0019648-K

Dec 23, 2025

226.0 KB

Dec 19, 2025

0001193125-25-3268914

Dec 17, 2025

9.6 KB

8-K

Dec 17, 2025

0001753926-25-0019068-K

Dec 17, 2025

213.7 KB

Dec 12, 2025

0001753926-25-001884

Dec 10, 2025

13.1 KB

ARS

Dec 1, 2025

0001753926-25-001847ARS

Dec 31, 2024

1.8 MB

Nov 26, 2025

0001753926-25-001831

Nov 25, 2025

11.4 KB

DEF 14A

Nov 25, 2025

0001753926-25-001827DEF 14A

Dec 17, 2025

1.3 MB

Nov 19, 2025

0001919246-25-000006

—

13.2 KB

SCHEDULE 13G/A

Nov 14, 2025

0001193125-25-283461

—

12.2 KB

PRE 14A

Nov 14, 2025

0001753926-25-001803

Nov 14, 2025

3.0 MB

SCHEDULE 13G

Nov 14, 2025

0001838556-25-000009

—

15.6 KB

8-K

Nov 13, 2025

0001753926-25-0017668-K

Nov 13, 2025

305.4 KB

10-Q

Nov 13, 2025

0001753926-25-00176410-Q

Sep 30, 2025

7.1 MB

Nov 10, 2025

0001193125-25-2744364

Nov 6, 2025

6.5 KB

SCHEDULE 13D/A

Nov 10, 2025

0001193125-25-274432

—

20.3 KB

25 filings shown

Pelthos Therapeutics Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(203 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
11/25/25	DEF 14A	DEF 14A	→
11/14/25	PRE 14A	PRE 14A	→
5/27/25	DEFM14C	DEFM14C	→
5/9/25	PREM14C	PREM14C	→
9/26/24	DEF 14A	DEF 14A	→
9/9/24	PRE 14A	PRE 14A	→

Filed	Form	Description
12/29/25	4	4	→
12/29/25	3	3	→
12/19/25	4	4	→
12/12/25	4	4	→
11/26/25	4	4	→
11/10/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	EFFECT	EFFECT	→
2/5/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/19/25	D	D	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓